B2DB — Who said what, where, and when

Pierrick Rollet

Alexion

Pierrick Rollet is listed as Alexion. Pierrick spoke at ISPOR Europe 2026 in November 2026 (speaker, “EU HTA System Readiness for Orphan Medicinal Products ahead of 13 January 2028”).

Compiled from published conference agendas; not yet confirmed by Pierrick. Is this you? Claim this profile.

About

Currently Vice President Global Head Value-Access & Pricing at Alexion Astra Zeneca Rare Diseases, Pierrick is a life science C level accomplished executive with over 25 years of international experience across senior general management roles at global, region and local level leading global commercial/market access strategy, business local-regional operations, global franchise development programs and global Business Development. With a large experience across 4 continents and speaking 5 languages, Pierrick is an agile international enterprise leader with integrated strategic thinking built upon an end-to-end understanding of leading and developing strategy & operations at global, region and local levels within both established and growth stage commercial biopharmaceutical companies. As Rare Diseases global executive committee team member, international Board director (JV board member, JV CEO in Japan) or Vice President global business development, Pierrick has a proven track r

Sessions at 1 conference

ISPOR Europe 2026 8 November 2026 – 11 November 2026